Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Ono Enters into a Multi Target R&D Collaboration Agreement with PrecisionLife

Thursday, December 15, 2022

Ono Pharmaceutical Co Ltd today announced that it has entered into a multi target RD collaboration agreement with PrecisionLife Limited a global techbio company generating the deepest insights into disease biology to create novel precision medicines...

UCB and Praxis Precision Medicines Announce Epilepsy Research Collaboration

Wednesday, December 14, 2022

UCB a global biopharmaceutical company and Praxis Precision Medicines Inc a clinicalstage biopharmaceutical company today announced a strategic collaboration based upon Praxis PRAX program for the discovery of small molecule therapeutics as potential...

Biosion Announces Research Collaboration with ImmunoGen to Create Novel Antibody-Drug Conjugates

Wednesday, December 14, 2022

Biosion USA Inc a global RD biotechnology company today announced an exploratory research collaboration to create antibodydrug conjugates ADCs for the treatment of cancer with ImmunoGen Inc a leader in developing next generation ADCs In the joint res...

Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.

Tuesday, December 13, 2022

Merck known as MSD outside of the United States and Canada is commencing today through a subsidiary a cash tender offer to purchase all outstanding shares of common stock of Imago BioSciences Inc Nasdaq IMGO On Nov Merck announced that it had enter...

Pasithea Therapeutics Announces Comprehensive Settlement Agreement with the Camac Group

Tuesday, December 13, 2022

Pasithea Therapeutics Corp a biotechnology company focused on the discovery research and development of innovative treatments for central nervous system CNS disorders today announced that it has reached a comprehensive Settlement and Cooperation Agre...

Efruxifermin Granted FDA Breakthrough Therapy Designation for NASH

Friday, December 09, 2022

Akero Therapeutics Inc a clinicalstage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need today announced that efruxifermin EFX has received a Breakthrough Therapy Designation...

Chugai and Towa Launch Edirol Tablet for Osteoporosis Treatment

Friday, December 09, 2022

Chugai Pharmaceutical Co Ltd and Towa Pharmaceutical Co Ltd announced that Towa launched Edirol Tablets g g generic name eldecalcitol hereafter Edirol Tablet for an osteoporosis treatment an active vitamin D preparation upon the listing of the natio...

Kite and Daiichi Sankyo Announce Changes to YESCARTA® CAR T-Cell Therapy Licensing Agreement in Japan

Thursday, December 08, 2022

Kite Pharma Inc a Gilead Company and Daiichi Sankyo Co Ltd today jointly announced the revision of their partnership agreement which gave Daiichi Sankyo exclusive rights to develop manufacture and commercialize Yescarta axicabtagene ciloleucel in Ja...

Aarvik Therapeutics Announces a Global Novel Payload Agreement with NJ Bio, Inc.

Thursday, December 08, 2022

Aarvik Therapeutics announces a global license and assignment Agreement with NJ Bio Inc to secure a class of novel proprietary payloads with a wide range of potencies Aarvik has an exclusive license to commercialize the novel proprietary payloads fro...

AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline

Wednesday, December 07, 2022

AbbVie and HotSpot Therapeutics Inc a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for the treatment of cancer and autoimmune diseases today announced an exclusive worldwide collaboration and o...